iBionext
Also known as Ibionext, iBionext Growth Fund
Paris health and deeptech venture studio and AMF-authorised fund manager; creates and finances start-ups through iBionext Growth Fund I (€90M final close, 2018), six portfolio companies.
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2016
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 3 people
Focus
- STAGES
- Pre-SeedSeedSeries ASeries BGrowth
- ASSET MIX
- Venture capitalDirect investments
- GEOGRAPHY
- France
Overview
iBionext is a Paris venture studio that creates, finances and supports start-ups developing medical and bio-inspired deeptech innovations, under a “Spot, Boost and Grow” model in which the same fund takes a majority stake at Series A and follows on through later rounds. Its first fund, iBionext Growth Fund, held a €46M first close in September 2016 and a €90M final close in February 2018, backed by about twenty investors. The fund built a portfolio of six companies — Prophesee, BrainEver, Chronolife, Tilak Healthcare, GrAI Matter Labs and T-Heart — which had raised more than €200M by end-2023. Its chairman is life-sciences entrepreneur Bernard Gilly.
Investment thesis
Breakthrough technologies in health (biotech, medtech, digital health) and bio-inspired, energy-efficient industrial deeptech sourced from academic and scientific networks; the studio matures projects, founds companies with a majority stake at Series A, and remains lead investor through growth and exit.
PORTFOLIO (6)
- PropheseeNOTABLEDeep Tech
- BrainEverBiotech & Life Sciences
- ChronolifeHealthTech
- Tilak HealthcareHealthTech
- GrAI Matter LabsArtificial Intelligence
- T-HeartHealthTech
People
Links
Frequently asked questions
iBionext is a VC fund based in Paris, France, founded in 2016.
Yes. iBionext invests its own capital in private companies.
iBionext invests at Pre-Seed, Seed, Series A, Series B and Growth stages in Biotech & Life Sciences, HealthTech, Deep Tech and Artificial Intelligence.
Key people at iBionext include Bernard Gilly (Chairman (Président)), Alexia Perouse (Managing Partner and CEO (Associée Directrice Générale)) and Stéphane Losik (Middle Office Manager & Investor Support).
iBionext's investments include Prophesee, BrainEver, Chronolife, Tilak Healthcare, GrAI Matter Labs and T-Heart.
The most recent publicly reported investment by iBionext is BrainEver (€33M Series B (led by Critical Path Ventures and the EIC; iBionext participating as existing investor)), announced in Jul 2025.
Yes. iBionext manages capital from outside investors.